Ignite Creation Date:
2025-12-24 @ 11:48 PM
Ignite Modification Date:
2026-03-07 @ 10:17 PM
Study NCT ID:
NCT00736151
Status:
COMPLETED
Last Update Posted:
2009-08-07
First Post:
2008-08-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Dose Titration Study in Patients With Neuropathic Pain
Sponsor:
Newron Pharmaceuticals SPA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NW-1029/001/II/2003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Stefano Rossetti, MD
Old Organization:
Newron Pharmaceuticals S.p.A